Cancer Research
Strength Training Fights Inflammaging in Bone Marrow Transplant Survivors
A 10-week supervised strength program targets chronic inflammation and self-efficacy in long-term allogeneic HCT survivors.
Clinical Trial
May 25, 2026 0
Results for "Telomere Interventions" in Cancer
20 articles
Cancer Research
Liquid Biopsy for Sarcoma: Can cfDNA and Telomere Mutations Predict Recurrence
Researchers explored whether cancer-derived cell-free DNA and telomere maintenance mutations could serve as early warning biomarkers in soft tissue sarcoma patients.
Clinical Trial
May 16, 2026 0
Cancer Research
Telomerase Vaccine Plus Checkpoint Blockade Targets HPV-Driven Cancers
A completed Phase 2 trial tests UCPVax cancer vaccine combined with atezolizumab in cervical, anal, and head-and-neck cancers.
Clinical Trial
May 10, 2026 0
Cancer Research
Trial Tests Whether Stopping Immunotherapy Early Harms NSCLC Patients Who Respond
A randomized Phase 2 trial investigates whether PD-1 inhibitor discontinuation after early response is safe in non-small cell lung cancer.
Clinical Trial
Jun 14, 2026 0
Cancer Research
16-Week Holistic Program Boosts Quality of Life in Cancer Survivors
A pilot trial tested a comprehensive physical, mental, and spiritual intervention for cancer survivors, tracking outcomes at 6 months post-program.
Clinical Trial
May 28, 2026 0
Cancer Research
Physical Therapy and Relaxation Techniques Boost Resilience in Older Lung Cancer Patients
A completed pilot trial tested physical therapy and progressive muscle relaxation to preserve function and mood in older adults with advanced lung cancer.
Clinical Trial
May 12, 2026 0
Cancer Research
Enhanced CAR-T Cell Therapy Shows Promise Against Treatment-Resistant Blood Cancers
Modified immune cells engineered to overcome cancer's defenses completed safety testing in lymphoma patients.
Clinical Trial
Mar 29, 2026 12
Cancer Research
Engineered Immune Cells Show Promise Against Advanced Cancer in Early Trial
Scientists modified patients' immune cells to better recognize and attack cancer tumors expressing NY-ESO-1 protein.
Clinical Trial
Mar 28, 2026 0
Cancer Research
PULSAR Radiation Plus IMSA101 Immunotherapy Trial in Oligoprogressive Cancers Terminated Early
A Phase 2 trial combining adaptive stereotactic radiotherapy with IMSA101 and checkpoint inhibitors was halted after enrolling only 16 patients.
Clinical Trial
May 14, 2026 0
Cancer Research
Modified T Cells Show Promise Against Childhood Blood Cancers in NCI Trial
Researchers modified children's own immune cells to fight B-cell leukemia and lymphoma when standard treatments failed.
Clinical Trial
Mar 28, 2026 0
Cancer Research
CAR-T Cell Therapy Shows Promise for Treatment-Resistant Blood Cancers
Small trial tests innovative immune cell therapy for patients with relapsed non-Hodgkin's lymphoma who failed standard treatments.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Turin Study Maps Why Multiple Myeloma Escapes Anti-CD38 Immunotherapy
Italian researchers track genomic and cellular changes in myeloma patients to uncover why anti-CD38 treatments stop working.
Clinical Trial
Jun 16, 2026 0
Cancer Research
Time-Restricted Eating Shows Promise for Breast Cancer Survivors Over 60
Eight-week study of weekday-only intermittent fasting in older breast cancer survivors with overweight demonstrates feasibility.
Clinical Trial
Mar 28, 2026 0
Cancer Research
HDAC Inhibitor Plus Checkpoint Blocker Tested in Advanced Lung Cancer Trial
A phase 1/2 trial combined mocetinostat and durvalumab in 83 patients with advanced solid tumors and NSCLC.
Clinical Trial
May 7, 2026 0
Cancer Research
Wearable Sensors Track Cancer Therapy Side Effects in Real-Time Stanford Study
Stanford researchers used smartwatches and blood tests to monitor dangerous side effects during cutting-edge CAR-T cancer treatment.
Clinical Trial
Mar 29, 2026 1
Cancer Research
New Cancer Immunotherapy IBI346 Shows Promise in Multiple Myeloma Trial
Small trial tests innovative treatment IBI346 for blood cancer patients who didn't respond to standard therapies.
Clinical Trial
Mar 28, 2026 1
Cancer Research
Engineered T Cells Show Promise Against Deadly Mesothelioma Cancer
Small trial tests modified immune cells injected directly into chest cavity to fight aggressive cancer with 12-month survival rate.
Clinical Trial
Mar 28, 2026 1
Cancer Research
Natural Killer Cell Therapy Shows Promise for Advanced Cancer Treatment
Autologous NK cell therapy combined with immunotherapy tested in 27 patients with treatment-resistant cancers.
Clinical Trial
Mar 29, 2026 0
Cancer Research
Triple Immune Checkpoint Blockade Tested in Advanced Solid Tumors
A Phase 1/2 trial explores combining KIR, PD-1, and CTLA-4 inhibitors to unlock stronger anti-tumor immunity.
Clinical Trial
May 20, 2026 0
Cancer Research
Metronomic Vinorelbine Plus Atezolizumab Tested as Second-Line NSCLC Therapy
A completed Phase 2 trial explores whether low-dose continuous chemotherapy can boost immunotherapy efficacy in advanced lung cancer.
Clinical Trial
Jun 9, 2026 0
Page 1 of 2Next